Aerie Pharmaceuticals (NASDAQ: AERI) shares bounced off a new 52-week high of $38.98 today. A number of other brokerage analysts have issued statements on the stock recently, and the company has earned a consensus one-year price target of $50.25, $34.94.…
Analysts at HC Wainwright initiated coverage on Aerie Pharmaceuticals Inc. (NASDAQ: AERI) stock, starting the company at Buy. The company currently has a rating of Buy on the shares. A number of other analysts have issued reports on the stock …
Aerie Pharmaceuticals Inc. (NASDAQ: AERI) had its price target boosted by equities researchers at Stifel Nicolaus from $40.00 to $50.00.Stifel Nicolaus currently has a rating of Buy on the shares. A number of other analysts have commented on the company …